Pfeiffer Vacuum: Q3 the best quarter in the company’s history
Pfeiffer Vacuum announces results for the first nine months of 2010
04-11-2010: Pfeiffer Vacuum closed the month of September with the best quarter ever in its corporate history. This also produced above-average developments for the first nine months. All metrics posted significant, double-digit growth rates.
Pfeiffer Vacuum Chief Executive Officer Manfred Bender had this to say about the results: “We are very proud of these numbers. The development of our business has far surpassed our expectations. The volume of new orders is overwhelming, and there has already been a clear improvement in margins during the first year of the Trinos integration. We therefore now anticipate sales revenues of around € 210 million for the full fiscal year, and an EBIT margin of over 23 percent.”
Sales revenues by region
The regional sales mix produced strong, double-digit growth rates on international markets during the first nine months of the 2010 fiscal year. In the United States, sales revenues improved by 42.2 percent to € 38.9 million (2009: € 27.4 million), and by 46.2 percent in Asia and the rest of the world to € 27.5 million (2009: € 18.8 million). In the other countries of Europe, sales revenues rose by 11.6 percent to € 41.0 million (2009: € 36.7 million). A special effect that was incurred last year due to a major contract from the solar industry has distorted year-on-year comparisons for Germany, causing sales revenues in Germany to decline by 6.4 percent from € 54.6 million to € 51.1 million. Currency translation effects accounted for € 3 million in the first nine months of 2010.
Sales revenues by market segment
Posting a triple-digit growth rate, the Semiconductor market was especially noteworthy in the sales revenue mix by markets, with Pfeiffer Vacuum recording an increase of 125.2 percent to € 17.1 million (2009: € 7.6 million). The Analytical segment, too, saw a significant 39.3-percent rise to € 45.6 million (2009: € 32.7 million). Sales revenues in Industrial Applications improved by 28.5 percent to € 34.6 million (2009: € 27.0 million). The Research & Development market segment continued to sustain its upward trend, with sales revenues advancing by 25.2 percent to € 30.9 million (2009: € 24.7 million). Following a number of negative quarters, the development of sales revenues in the Chemical and Process Technology segment developed on a highly positive note, rising by 18.2 percent to € 6.4 million (2009: € 5.4 million). Only in the Coating segment was there a significant 40.5-percent year-on-year decline in sales revenues to € 23.8 million (2009: € 40.1 million).
Further profitability numbers
Pfeiffer Vacuum’s industry-leading profitability continued to improve during the first nine months of fiscal 2010. Operating profit rose by 33.8 percent to € 37.1 million (2009: € 27.7 million), while the EBIT margin increased by 3.2 percentage points to 23.4 percent. Net income advanced by 47.1 percent to € 29.0 million (2009: € 19.7 million), with earnings per share thus amounting to € 3.39 (2009: € 2.31).
Contact / Request information
Request further information free of charge:
- Pfeiffer Vacuum
- Garner Aldehyde
- Lawesson’s Reagent
- Martin’s Sulfurane
- Mosher’s Acid
- Ohira-Bestmann Reagent
- Reissert Compound
- solar industry
- process technology
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2Fast new, 1-step genetic engineering technology
- 3Analytik Jena receives major order for diagnostic detection systems from Pakistan
- 4Fluorescence spectroscopy using a smartphone
- 5Molecular switch for cheaper biofuel
- 6Genzyme Launches New Diagnostic Test for Common Blood Cancer
- 7Malvern Instruments announces global agreement with Proveris Scientific
- 8Thermo Fisher Scientific Scientist Dr. Alexander Makarov Receives Inaugural HUPO Science and Technology Award
- 9LIMS/LIS Market and POCT Supplement
- 10PIAB announces new Chief Executive Officer
- Merck’s credit rating raised by Standard & Poor’s to ‘A’
- Carl Zeiss Meditec improves its results in first six months of financial yea ...
- ZEISS presents half-year financial figures
- Analytik Jena announces group figures for the first half of the financial ye ...
- Analytik Jena announces forecast for financial year 2012/2013
- ZEISS to acquire Xradia to complement its microscopy business
- Luminous bacterial proteins detect chemicals in water
- Merck’s credit rating raised by Standard & Poor’s to ‘A’
- Analytik Jena receives major order for diagnostic detection systems from Pakistan
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013





